• Feb 26, 2025

Teladoc’s (NYSE:TDOC) Q4 Earnings Results: Revenue In Line With Expectations But Stock Drops 11.7%

Digital medical services platform Teladoc Health (NYSE:TDOC) met Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 3% year on year to $640.5 million. On the other hand, next quarter’s revenue guidance of $618.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its GAAP loss of $0.28 per share was 26.1% below analysts’ consensus estimates.

  • Feb 26, 2025

FTAI Aviation (NASDAQ:FTAI) Beats Q4 Sales Targets

Aircraft leasing company FTAI Aviation (NASDAQ:FTAI) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 59.5% year on year to $498.8 million. Its GAAP profit of $0.84 per share was 6.1% below analysts’ consensus estimates.

  • Feb 26, 2025

Sweetgreen (NYSE:SG) Posts Q4 Sales In Line With Estimates But Stock Drops 16.1%

Casual salad chain Sweetgreen (NYSE:SG) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 5.1% year on year to $160.9 million. On the other hand, next quarter’s revenue guidance of $164.5 million was less impressive, coming in 7.7% below analysts’ estimates. Its GAAP loss of $0.25 per share was 16.4% below analysts’ consensus estimates.

  • Feb 26, 2025

LegalZoom (NASDAQ:LZ) Beats Q4 Sales Targets, Stock Soars

Online legal service provider LegalZoom (NASDAQ:LZ) reported revenue ahead of Wall Street’s expectations in Q4 CY2024, with sales up 1.9% year on year to $161.7 million. Guidance for next quarter’s revenue was better than expected at $177 million at the midpoint, 1% above analysts’ estimates. Its GAAP profit of $0.07 per share was in line with analysts’ consensus estimates.

  • Feb 26, 2025

C3.ai’s (NYSE:AI) Q4: Beats On Revenue But Stock Drops

Artificial intelligence (AI) software company C3.ai (NYSE:AI) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 26% year on year to $98.78 million. The company expects next quarter’s revenue to be around $108.6 million, close to analysts’ estimates. Its non-GAAP loss of $0.12 per share was 52% above analysts’ consensus estimates.

  • Feb 26, 2025

Tandem Diabetes’s (NASDAQ:TNDM) Q4 Sales Beat Estimates But Stock Drops 12.2%

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q4 CY2024, with sales up 35% year on year to $282.6 million. The company expects next quarter’s revenue to be around $221.5 million, coming in 1.3% above analysts’ estimates. Its GAAP profit of $0.01 per share was significantly above analysts’ consensus estimates.

  • Feb 26, 2025

Bitcoin’s slide has traders hedging against a drop to $70,000

(Bloomberg) -- With the so-called Trump bump fading across markets, Bitcoin options are showing that investors and traders are hedging against a decline in the cryptocurrency to levels last seen just after election day. Most Read from BloombergThe Trump Administration Takes Aim at Transportation ResearchShelters Await Billions in Federal Money for Homelessness ProvidersNYC’s Congestion Pricing Pulls In $48.6 Million in First MonthNew York’s Congestion Pricing Plan Faces Another Legal ShowdownNYC